Nutanix, Inc. Class A Common Stock
NTNXNasdaqCIK 1618732Technology / Softwarefiscal year ends July44 quarters since 2015
Latest quarter Q4 FY2026, filed September 18, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q1 FY2023 to Q4 FY2026, through the filing of September 18, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q4 FY2026 filed September 18, 2026.
| Millions of dollars | Q4 FY2026ended Jul 31, 2026filed Sep 18, 2026 | Q3 FY2026ended Apr 30, 2026filed May 29, 2026 | Q2 FY2026ended Jan 31, 2026filed Mar 2, 2026 | Q1 FY2026ended Oct 31, 2025filed Dec 4, 2025 | Q4 FY2025ended Jul 31, 2025filed Sep 24, 2025 | Q3 FY2025ended Apr 30, 2025filed Jun 3, 2025 | Q2 FY2025ended Jan 31, 2025filed Mar 6, 2025 | Q1 FY2025ended Oct 31, 2024filed Dec 5, 2024 | YoYQ4 FY2026vs Q4 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 757 | 703 | 723 | 671 | 653 | 639 | 655 | 591 | +15.9% |
| Cost of revenue | 106 | 92 | 91 | 87 | 84 | 83 | 85 | 83 | +26.1% |
| Gross profit | 651 | 611 | 632 | 583 | 569 | 556 | 569 | 508 | +14.4% |
| Research and development | 205 | 196 | 202 | 187 | 194 | 186 | 183 | 174 | +5.9% |
| Selling, general and administrative | 72 | 61 | 68 | 61 | 63 | 61 | 60 | 54 | +14.4% |
| Operating income | 70 | 71 | 84 | 49 | 31 | 49 | 65 | 27 | +124.3% |
| Other income (expense) | 13 | 11 | 13 | 16 | 14 | 16 | 0 | 10 | −8.7% |
| Pretax income | 83 | 81 | 98 | 66 | 45 | 65 | 65 | 37 | +83.2% |
| Income tax | (1,187) | 9 | (6) | 3 | 6 | 1 | 9 | 7 | −18379.9% |
| Net income | 1,270 | 72 | 103 | 62 | 39 | 63 | 56 | 30 | +3184.9% |
| Diluted EPS ($) | — | 0.25 | 0.36 | 0.21 | — | 0.22 | 0.19 | 0.10 | — |
| Diluted shares (millions) | — | 287* | 292* | 297* | — | 297* | 293* | 289* | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q4 FY2026 filed September 18, 2026.
| Millions of dollars | Q4 FY2026ended Jul 31, 2026filed Sep 18, 2026 | Q3 FY2026ended Apr 30, 2026filed May 29, 2026 | Q2 FY2026ended Jan 31, 2026filed Mar 2, 2026 | Q1 FY2026ended Oct 31, 2025filed Dec 4, 2025 | Q4 FY2025ended Jul 31, 2025filed Sep 24, 2025 | Q3 FY2025ended Apr 30, 2025filed Jun 3, 2025 | Q2 FY2025ended Jan 31, 2025filed Mar 6, 2025 | Q1 FY2025ended Oct 31, 2024filed Dec 5, 2024 | YoYQ4 FY2026vs Q4 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 777 | 719 | 603 | 780 | 770 | 873 | 1,072 | 717 | +1.0% |
| Short-term investments | 1,584 | 1,299 | 1,271 | 1,282 | 1,223 | 1,010 | 671 | 359 | +29.5% |
| Total current assets | 3,029 | 2,612 | 2,466 | 2,639 | 2,589 | 2,411 | 2,335 | 1,523 | +17.0% |
| Total assets | 5,074 | 3,419 | 3,277 | 3,324 | 3,283 | 3,097 | 2,989 | 2,181 | +54.5% |
| Total current liabilities | 1,684 | 1,470 | 1,491 | 1,400 | 1,414 | 1,282 | 1,318 | 1,221 | +19.1% |
| Long-term debt | — | — | — | — | — | — | — | — | — |
| Total liabilities | 4,371 | 4,144 | 4,108 | 3,993 | 3,978 | 3,808 | 3,797 | 2,867 | +9.9% |
| Stockholders’ equity | 703 | (726) | (831) | (669) | (695) | (711) | (808) | (685) | +201.2% |
| Shares outstanding (millions) | 271 | 270 | 265 | 270 | 269 | 268 | 267 | 268 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q4 FY2026 filed September 18, 2026.
| Millions of dollars | Q4 FY2026ended Jul 31, 2026filed Sep 18, 2026 | Q3 FY2026ended Apr 30, 2026filed May 29, 2026 | Q2 FY2026ended Jan 31, 2026filed Mar 2, 2026 | Q1 FY2026ended Oct 31, 2025filed Dec 4, 2025 | Q4 FY2025ended Jul 31, 2025filed Sep 24, 2025 | Q3 FY2025ended Apr 30, 2025filed Jun 3, 2025 | Q2 FY2025ended Jan 31, 2025filed Mar 6, 2025 | Q1 FY2025ended Oct 31, 2024filed Dec 5, 2024 | YoYQ4 FY2026vs Q4 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 315 | 208 | 197 | 197 | 220 | 219 | 222 | 162 | +43.5% |
| Capital expenditures | 37 | 10 | 6 | 22 | 12 | 15 | 35 | 10 | +218.7% |
| Free cash flow (CFO − capex) | 278 | 197 | 191 | 175 | 208 | 203 | 187 | 152 | +33.6% |
| Depreciation and amortization | 17 | 17 | 18 | 18 | 18 | 18 | 18 | 18 | −6.5% |
| Share repurchases | 50 | 50 | 333 | 50 | 50 | 38 | 200 | 20 | +0.5% |
| Dividends paid | — | — | — | — | — | — | — | — | — |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2026 filed September 18, 2026.
Income statement
| Millions of dollars | FY2026ended Jul 31, 2026filed Sep 18, 2026 | FY2025ended Jul 31, 2025filed Sep 24, 2025 | FY2024ended Jul 31, 2024filed Sep 19, 2024 | FY2023ended Jul 31, 2023filed Sep 21, 2023 | FY2022ended Jul 31, 2022filed Sep 21, 2022 | FY2021ended Jul 31, 2021filed Sep 21, 2021 | FY2020ended Jul 31, 2020filed Sep 23, 2020 | FY2019ended Jul 31, 2019filed Sep 24, 2019 | FY2018ended Jul 31, 2018filed Sep 24, 2018 | FY2017ended Jul 31, 2017filed Sep 18, 2017 | FY2016ended Jul 31, 2016filed Dec 8, 2016 | FY2015ended Jul 31, 2015filed Dec 8, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,854 | 2,538 | 2,149 | 1,863 | 1,581 | 1,394 | 1,308 | 1,236 | 1,155 | 846 | 503 | 241 |
| Cost of revenue | 377 | 335 | 324 | 332 | 321 | 292 | 287 | 304 | 386 | 327 | 171 | 101 |
| Gross profit | 2,477 | 2,203 | 1,825 | 1,531 | 1,260 | 1,102 | 1,021 | 932 | 769 | 519 | 333 | 140 |
| Research and development | 791 | 737 | 639 | 581 | 573 | 558 | 554 | 501 | 314 | 289 | 116 | 74 |
| Selling, general and administrative | 262 | 237 | 201 | 232 | 166 | 154 | 136 | 120 | 86 | 77 | 34 | 24 |
| Operating income | 274 | 173 | 8 | (207) | (459) | (662) | (829) | (598) | (280) | (348) | (105) | (119) |
| Other income (expense) | 53 | 39 | (109) | (26) | (321) | (355) | (26) | (15) | (9) | (26) | (1) | (6) |
| Pretax income | 327 | 212 | (101) | (234) | (780) | (1,017) | (855) | (613) | (290) | (375) | (106) | (125) |
| Income tax | (1,180) | 23 | 23 | 21 | 19 | 18 | 18 | 8 | 7 | 5 | 2 | 2 |
| Net income | 1,507 | 188 | (125) | 1,507 | (799) | (1,036) | (873) | (621) | (297) | (380) | (108) | (126) |
| Diluted EPS ($) | 5.17 | 0.65 | (0.51) | (1.09) | (3.62) | (5.02) | (4.48) | — | — | — | — | — |
| Diluted shares (millions) | 292* | 294* | 245* | 233* | 221* | 206* | 195* | — | — | — | — | — |
Balance sheet
| Millions of dollars | FY2026ended Jul 31, 2026filed Sep 18, 2026 | FY2025ended Jul 31, 2025filed Sep 24, 2025 | FY2024ended Jul 31, 2024filed Sep 19, 2024 | FY2023ended Jul 31, 2023filed Sep 21, 2023 | FY2022ended Jul 31, 2022filed Sep 21, 2022 | FY2021ended Jul 31, 2021filed Sep 21, 2021 | FY2020ended Jul 31, 2020filed Sep 23, 2020 | FY2019ended Jul 31, 2019filed Sep 24, 2019 | FY2018ended Jul 31, 2018filed Sep 24, 2018 | FY2017ended Jul 31, 2017filed Sep 18, 2017 | FY2016ended Jul 31, 2016filed Dec 8, 2016 | FY2015ended Jul 31, 2015filed Dec 8, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 777 | 770 | 655 | 513 | 403 | 286 | 319 | 397 | 306 | 138 | 99 | 68 |
| Short-term investments | 1,584 | 1,223 | 339 | 924 | 921 | 928 | 401 | 512 | 628 | 211 | 86 | — |
| Total current assets | 3,029 | 2,589 | 1,481 | 1,862 | 1,658 | 1,562 | 1,094 | 1,275 | 1,263 | 580 | 330 | — |
| Total assets | 5,074 | 3,283 | 2,144 | 2,527 | 2,366 | 2,277 | 1,769 | 1,786 | 1,600 | 738 | 399 | — |
| Total current liabilities | 1,684 | 1,414 | 1,244 | 1,136 | 1,161 | 928 | 760 | 599 | 458 | 311 | 213 | — |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | — | — |
| Total liabilities | 4,371 | 3,978 | 2,872 | 3,234 | 3,166 | 3,290 | 2,044 | 1,599 | 1,273 | 521 | 465 | — |
| Stockholders’ equity | 703 | (695) | (728) | (707) | (801) | (1,021) | (283) | 187 | 327 | 217 | (286) | (235) |
| Shares outstanding (millions) | 271 | 269 | 265 | 240 | 227 | — | — | — | — | — | — | — |
Cash flow statement
| Millions of dollars | FY2026ended Jul 31, 2026filed Sep 18, 2026 | FY2025ended Jul 31, 2025filed Sep 24, 2025 | FY2024ended Jul 31, 2024filed Sep 19, 2024 | FY2023ended Jul 31, 2023filed Sep 21, 2023 | FY2022ended Jul 31, 2022filed Sep 21, 2022 | FY2021ended Jul 31, 2021filed Sep 21, 2021 | FY2020ended Jul 31, 2020filed Sep 23, 2020 | FY2019ended Jul 31, 2019filed Sep 24, 2019 | FY2018ended Jul 31, 2018filed Sep 24, 2018 | FY2017ended Jul 31, 2017filed Sep 18, 2017 | FY2016ended Jul 31, 2016filed Dec 8, 2016 | FY2015ended Jul 31, 2015filed Dec 8, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 917 | 821 | 673 | 272 | 68 | (100) | (160) | 42 | 93 | 15 | 4 | (26) |
| Capital expenditures | 76 | 71 | 75 | 65 | 49 | 59 | 89 | 118 | 62 | 50 | 42 | 23 |
| Free cash flow (CFO − capex) | 841 | 750 | 598 | 207 | 18 | (158) | (249) | (76) | 30 | (35) | (39) | (49) |
| Depreciation and amortization | 71 | 73 | 73 | 76 | 88 | 94 | 94 | 78 | 50 | 38 | 26 | 17 |
| Share repurchases | 484 | 308 | 131 | 0 | 59 | 125 | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Sivaraman Rukmini | Chief Financial Officer | open-market sale10b5-1 | 180,123 | $74.33 | $13M | 145,364 | Oct 13, 2026 |
| Oct 12, 2026 | Sivaraman Rukmini | Chief Financial Officer | open-market sale10b5-1 | 52,589 | $75.33 | $4M | 92,775 | Oct 13, 2026 |
| Oct 9, 2026 | Sheppard Teresa Gayle | Director | open-market sale10b5-1 | 2,800 | $73.56 | $206K | 24,188 | Oct 9, 2026 |
| Oct 9, 2026 | Sheppard Teresa Gayle | Director | open-market sale10b5-1 | 700 | $74.14 | $52K | 23,488 | Oct 9, 2026 |
| Oct 7, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | open-market sale10b5-1 | 75,045 | $74.00 | $6M | 414,339 | Oct 8, 2026 |
| Oct 6, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | open-market sale10b5-1 | 179,490 | $73.35 | $13M | 634,849 | Oct 8, 2026 |
| Oct 6, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | open-market sale10b5-1 | 145,465 | $73.84 | $11M | 489,384 | Oct 8, 2026 |
| Sep 24, 2026 | Maner Tarkan | President and CCO | open-market sale | 69,778 | $68.23 | $5M | 33,647 | Sep 25, 2026 |
| Sep 17, 2026 | Sivaraman Rukmini | Chief Financial Officer | open-market sale10b5-1 | 38,139 | $70.00 | $3M | 325,487 | Sep 17, 2026 |
| Sep 15, 2026 | Sivaraman Rukmini | Chief Financial Officer | option exercise | 6,250 | $0.00 | — | 427,834 | Sep 17, 2026 |
| Sep 15, 2026 | Sivaraman Rukmini | Chief Financial Officer | option exercise | 4,765 | $0.00 | — | 432,599 | Sep 17, 2026 |
| Sep 15, 2026 | Sivaraman Rukmini | Chief Financial Officer | option exercise | 2,978 | $0.00 | — | 435,577 | Sep 17, 2026 |
| Sep 15, 2026 | Sivaraman Rukmini | Chief Financial Officer | option exercise | 3,396 | $0.00 | — | 438,973 | Sep 17, 2026 |
| Sep 15, 2026 | Sivaraman Rukmini | Chief Financial Officer | tax withholding | 75,347 | $67.99 | $5M | 363,626 | Sep 17, 2026 |
| Sep 15, 2026 | Martin Brian | Chief Legal Officer | option exercise | 2,825 | $0.00 | — | 39,344 | Sep 17, 2026 |
| Sep 15, 2026 | Martin Brian | Chief Legal Officer | option exercise | 1,902 | $0.00 | — | 41,246 | Sep 17, 2026 |
| Sep 15, 2026 | Martin Brian | Chief Legal Officer | tax withholding | 12,570 | $67.99 | $855K | 28,676 | Sep 17, 2026 |
| Sep 15, 2026 | Maner Tarkan | President and CCO | option exercise | 4,792 | $0.00 | — | 139,852 | Sep 17, 2026 |
| Sep 15, 2026 | Maner Tarkan | President and CCO | option exercise | 2,647 | $0.00 | — | 142,499 | Sep 17, 2026 |
| Sep 15, 2026 | Maner Tarkan | President and CCO | option exercise | 1,701 | $0.00 | — | 144,200 | Sep 17, 2026 |
| Sep 15, 2026 | Maner Tarkan | President and CCO | option exercise | 1,902 | $0.00 | — | 146,102 | Sep 17, 2026 |
| Sep 15, 2026 | Maner Tarkan | President and CCO | tax withholding | 42,677 | $67.99 | $3M | 103,425 | Sep 17, 2026 |
| Sep 15, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | option exercise | 17,207 | $0.00 | — | 1M | Sep 17, 2026 |
| Sep 15, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | option exercise | 15,885 | $0.00 | — | 1M | Sep 17, 2026 |
| Sep 15, 2026 | Ramaswami Rajiv | Chief Executive Officer, Director | option exercise | 8,508 | $0.00 | — | 1M | Sep 17, 2026 |
Full insider history for Nutanix, Inc. Class A Common Stock, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held NTNX in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded NTNX by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Fundsmith | Terry Smith | Q2 2026 | $27M | 538,281 | 0.20% | trimmed −6.8% |
Sources
Fiscal year ends in month 7; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- NUTANIX, INC., CIK 1618732 on EDGAR
- Extract generated
- November 1, 2026
- Withheld
- 5 line-years whose four quarters do not sum to the filed year: gross profit FY2016, net income FY2016, operating income FY2016, pretax income FY2016, revenue FY2016
- Repaired
- none
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, SalesRevenueNetCostOfGoodsAndServicesSoldGrossProfitResearchAndDevelopmentExpenseGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAvailableForSaleSecuritiesDebtSecuritiesCurrentAssetsCurrentAssetsLiabilitiesCurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockThe data
The statements on this page as files, generated November 1, 2026.
- JSON file
/data/financials/NTNX.json